From: Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer
Variables
HR
95% CI
p
Disease-free survival
TRAIL-R3 in TEpC
3.566
1.164–10.920
0.026
Metastasis-free survival
Tumor size
8.210
2.013–33.477
0.003
CCR-2 in TEpC
10.257
2.569–40.947
0.001
Overall survival
5.741
1.113–29.621
0.037